BAY 41-2272
SIGMA/B8810 - ≥97% (HPLC)
Synonym: 3-
CAS Number: 256376-24-6
Empirical Formula (Hill Notation): C20H17FN6
Molecular Weight: 360.39
MDL Number: MFCD06411391
Linear Formula: C20H17FN6
Product Type: Chemical
| assay | ≥97% (HPLC) |
| color | white to light brown |
| form | powder |
| InChI | 1S/C20H17FN6/c21-16-6-2-1 |
| InChI key | ATOAHNRJAXSBOR-UHFFFAOYSA |
| mp | 210.5-211.4 °C |
| originator | Bayer |
| Quality Level | 100 ![]() |
| SMILES string | Nc1nc(ncc1C2CC2)-c3nn(Cc4 |
| solubility | DMSO: 5 mg/mL, clear (warmed) |
| storage temp. | 2-8°C |
| Application: | BAY 41-2272 has been used for the stimulation of guanylate cyclase in heart and neurons. |
| Biochem/physiol Actions: | BAY 41-2272 is an activator of soluble guanylate cyclase at a novel, NO-independent regulatory site. BAY 41-2272 is the first product that stimulates sGC through a non-NO mechanism. BAY 41-2272 inhibits platelet aggregation and induces vasorelaxation without nitrate tolerance. |
| Biochem/physiol Actions: | BAY 41-2272 is an activator of soluble guanylate cyclase; stimulates sGC through a non-NO mechanism; inhibits platelet aggregation, and induces vasorelaxation without nitrate tolerance. |
| Features and Benefits: | This compound was developed by Bayer . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 5, 25 mg in glass bottle |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥97% (HPLC) |
| mp | 210.5-211.4 °C |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

